Wake-up Call: The Johnson & Johnson Prescription Pricing Scandal
It’s finally happened. After years of speculating what an employee complaint against an employer for breach of fiduciary duty would look like, it has arrived. And this one doesn’t disappoint. Johnson & Johnson is being sued by its employees, alleging that their health plan overpaid for prescription drugs, costing workers money. This suit touches on […]
Optimism in the Journey To Value-Based Healthcare
In the last episode of 2023, MTVA team leaders Jeff Hogan, John Rodis, MD, and Lisa Trumble dish out candid insights into the state of value-based healthcare and take a glimpse into 2024. They unpack the trend of primary care physicians shifting gears from employment to independence, delve into the pivotal role of employers in […]
Unraveling the Complexities of Pharmacy Benefits: PBMs, Drug Pricing vs. Drug Efficacy
The MTVA team engages in a thought-provoking conversation with AJ Loiacono, CEO and Founder of Capital Rx, delving into the intricacies of pharmacy benefits and the challenges faced by employers in navigating the healthcare landscape. Loiacono provides insights into the complexities of drug pricing, the far-reaching effects of the Consolidated Appropriations Act (CAA), high-cost drugs, […]
A Rising Tide Lifts All Boats: How one healthcare institution inspires transformation through data-driven
Moving to Value Alliance 11/1/2023 The MTVA team talks to Dr. James Caillouette, the visionary behind Hoag Orthopedic Institute, a joint venture orthopedic specialty hospital in Irvine, California, about the path to the establishment of a groundbreaking healthcare institution that prioritizes shared ownership and governance between hospitals and physicians. Jamie discusses the factors that drove […]
